Observational study of elderly patients with heart attacks
Official title: Hospital Registry of Patients with Myocardial Infarction in Individuals Aged 75 Years and Older
Run by Ryazan State Medical University · NCT06860646 · Data updated 2026-11-12
This study looks at older patients who have had heart attacks to see how their age affects their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Ryazan State Medical University Academic / other |
| Locations | 1 site (Ryazan) |
| Status | Recruiting |
| Started | September 1, 2020 |
| Main results expected | September 2028 |
| Study ends | December 2030 |
| Registry record updated | March 6, 2025 |
| Trial ID | NCT06860646 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 75 years and older with a confirmed diagnosis of myocardial infarction.
✕Probably not a fit
Patients younger than 75 years or those without a diagnosis of myocardial infarction will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry study focuses on patients aged 75 years and older who have been diagnosed with myocardial infarction. It aims to collect and analyze clinical, instrumental, demographic, and prognostic data to better understand the outcomes and characteristics of this age group. The study began in 2020 and employs statistical analysis to identify significant differences in the collected data. The findings may provide insights into the management of myocardial infarction in elderly patients.
Why it matters
Potential benefit: If successful, this study could enhance understanding of myocardial infarction in elderly patients, leading to improved treatment strategies.
How similar studies have gone: While there may be other studies on myocardial infarction, this specific focus on elderly patients is relatively novel and underexplored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- age 75 years and older, presence of an established diagnosis of myocardial infarction at the time of hospitalization. Exclusion Criteria: \-
Where it's running
-
State Budgetary Institution of the Ryazan Region "Regional Clinical Cardiology Dispensary"
Ryazan, Russia Recruiting
Study contacts
- Study coordinator: Arzu Arifovna Gurbanova
- Email: gurbanovaarzu2@gmail.com
- Phone: +79065434452
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risk of malignant arrhythmias after acute coronary syndrome
This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Optimal timing of staged complete revascularization in STEMI with multivessel disease
This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.
-
BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel
This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.
-
Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells
Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.
-
Abbreviated antithrombotic therapy after PCI in AF and MI
This trial tests whether DOAC-only therapy works as well as DOAC plus clopidogrel after PCI in people with atrial fibrillation and a recent heart attack.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.